Exploiting collateral damage

Ben Lehner () and Solip Park
Additional contact information
Ben Lehner: Ben Lehner and Solip Park are in the EMBL-CRG Systems Biology Unit, Centre for Genomic Regulation, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Solip Park: Ben Lehner and Solip Park are in the EMBL-CRG Systems Biology Unit, Centre for Genomic Regulation, Universitat Pompeu Fabra, 08003 Barcelona, Spain.

Nature, 2012, vol. 488, issue 7411, 284-285

Abstract: Some mutations in tumour cells play no part in causing cancer, but they generate cellular weak spots that may allow tumour cells to be selectively killed by drugs. See Article p.337

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/488284a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:488:y:2012:i:7411:d:10.1038_488284a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/488284a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().